Annual accounts receivable:
$53.98M+$12.85M(+31.26%)Summary
- As of today (May 21, 2025), CORT annual accounts receivable is $53.98 million, with the most recent change of +$12.85 million (+31.26%) on December 31, 2024.
- During the last 3 years, CORT annual accounts receivable has risen by +$26.35 million (+95.39%).
- CORT annual accounts receivable is now at all-time high.
Performance
CORT Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$61.82M+$7.84M(+14.53%)Summary
- As of today (May 21, 2025), CORT quarterly accounts receivable is $61.82 million, with the most recent change of +$7.84 million (+14.53%) on March 31, 2025.
- Over the past year, CORT quarterly accounts receivable has increased by +$301.00 thousand (+0.49%).
- CORT quarterly accounts receivable is now at all-time high.
Performance
CORT Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CORT Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.3% | +0.5% |
| 3 y3 years | +95.4% | +127.5% |
| 5 y5 years | +170.9% | +131.7% |
CORT Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.4% | at high | +127.5% |
| 5 y | 5-year | at high | +170.9% | at high | +181.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
CORT Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $61.82M(+14.5%) |
| Dec 2024 | $53.98M(+31.3%) | $53.98M(-9.6%) |
| Sep 2024 | - | $59.72M(+10.9%) |
| Jun 2024 | - | $53.84M(-12.5%) |
| Mar 2024 | - | $61.52M(+49.6%) |
| Dec 2023 | $41.12M(+32.4%) | $41.12M(+18.8%) |
| Sep 2023 | - | $34.63M(+6.4%) |
| Jun 2023 | - | $32.55M(-0.0%) |
| Mar 2023 | - | $32.56M(+4.8%) |
| Dec 2022 | $31.06M(+12.4%) | $31.06M(+5.6%) |
| Sep 2022 | - | $29.41M(+4.4%) |
| Jun 2022 | - | $28.16M(+3.6%) |
| Mar 2022 | - | $27.18M(-1.6%) |
| Dec 2021 | $27.63M(+5.4%) | $27.63M(+4.2%) |
| Sep 2021 | - | $26.51M(-4.0%) |
| Jun 2021 | - | $27.62M(+24.4%) |
| Mar 2021 | - | $22.20M(-15.3%) |
| Dec 2020 | $26.20M(+31.5%) | $26.20M(+19.3%) |
| Sep 2020 | - | $21.96M(-3.4%) |
| Jun 2020 | - | $22.73M(-14.8%) |
| Mar 2020 | - | $26.68M(+33.9%) |
| Dec 2019 | $19.93M(+13.3%) | $19.93M(-11.1%) |
| Sep 2019 | - | $22.41M(+13.3%) |
| Jun 2019 | - | $19.77M(+2.9%) |
| Mar 2019 | - | $19.22M(+9.3%) |
| Dec 2018 | $17.59M | $17.59M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $19.36M(-32.6%) |
| Jun 2018 | - | $28.70M(+66.3%) |
| Mar 2018 | - | $17.26M(+12.8%) |
| Dec 2017 | $15.30M(+55.2%) | $15.30M(+28.9%) |
| Sep 2017 | - | $11.87M(+24.9%) |
| Jun 2017 | - | $9.50M(+3.1%) |
| Mar 2017 | - | $9.21M(-6.6%) |
| Dec 2016 | $9.86M(+58.5%) | $9.86M(+19.7%) |
| Sep 2016 | - | $8.24M(-11.5%) |
| Jun 2016 | - | $9.30M(+37.8%) |
| Mar 2016 | - | $6.75M(+8.5%) |
| Dec 2015 | $6.22M(+86.6%) | $6.22M(+4.6%) |
| Sep 2015 | - | $5.95M(+20.1%) |
| Jun 2015 | - | $4.95M(+15.1%) |
| Mar 2015 | - | $4.30M(+29.0%) |
| Dec 2014 | $3.33M(+133.5%) | $3.33M(+21.4%) |
| Sep 2014 | - | $2.75M(+23.4%) |
| Jun 2014 | - | $2.23M(+15.8%) |
| Mar 2014 | - | $1.92M(+34.6%) |
| Dec 2013 | $1.43M(+156.4%) | $1.43M(+40.1%) |
| Sep 2013 | - | $1.02M(+19.2%) |
| Jun 2013 | - | $855.00K(-25.2%) |
| Mar 2013 | - | $1.14M(+105.2%) |
| Dec 2012 | $557.00K(>+9900.0%) | $557.00K(+57.3%) |
| Sep 2012 | - | $354.00K(-0.3%) |
| Jun 2012 | - | $355.00K(>+9900.0%) |
| Dec 2011 | $0.00 | $0.00 |
FAQ
- What is Corcept Therapeutics Incorporated annual accounts receivable?
- What is the all time high annual accounts receivable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual accounts receivable year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly accounts receivable year-on-year change?
What is Corcept Therapeutics Incorporated annual accounts receivable?
The current annual accounts receivable of CORT is $53.98M
What is the all time high annual accounts receivable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual accounts receivable is $53.98M
What is Corcept Therapeutics Incorporated annual accounts receivable year-on-year change?
Over the past year, CORT annual accounts receivable has changed by +$12.85M (+31.26%)
What is Corcept Therapeutics Incorporated quarterly accounts receivable?
The current quarterly accounts receivable of CORT is $61.82M
What is the all time high quarterly accounts receivable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly accounts receivable is $61.82M
What is Corcept Therapeutics Incorporated quarterly accounts receivable year-on-year change?
Over the past year, CORT quarterly accounts receivable has changed by +$301.00K (+0.49%)